MEDTECH & HEALTHTECH STARTUP 
STAGE (PRE-SERIES A)

Designed exclusively for medtech & healthtech startups.

BOOK TICKETS

Hosted by:

Astellas Rx+


10:30 Biomedical Bonding-2

 


10:40 _Brightmind.AI - 300 150

 


10:50 Acorai Logo

 


11:00 4Tissue Logo

 


11:10 domore diagnostics

 


11:20 Medentee

 


11:30 Lifespin GmbH Logo

 


11:40 Microsynetics

 


11:50 Plexāā

 


12:00

Seeding Change: Challenges and Opportunities for Medtech and Healthtech Spin-Out Funding 

Medtech and Healthtech spin-outs seeking seed funding face a variety of obstacles in the current funding climate. Yet, with their academic expertise, cutting-edge research, and transformative technologies, there is an abundance of potential growth and innovation opportunities to help shape the healthcare industry. A panel of investors discuss how spin-outs can avoid getting stuck at the first hurdles. 

  • How do investors assess the potential of early-stage spin-outs to overcome funding challenges and achieve sustained growth in a competitive market with less capital available? 
  • What strategies do successful spin-outs employ to navigate the current funding environment?
  • How do investors approach evaluating the market adoption potential and long-term viability of these ventures?
Moderator: Richard Cassidy, SVP, Rx+ Business Accelerator, Astella
Marion Bernard, Chief Investment Officer, Northern Gritstone 
Erki Mölder,
Managing Partner, Verge HealthTech Fund
Rebecca Todd, Investment Director, Longwall Venture Partners

Richard Cassidy, VP Rx+Global, Astellas Pharma  Marion Bernard, Chief Investment Officer, Northern Gritstone  Erki Mölder, Managing Partner, Verge HealthTech Fund  Rebecca Todd, Investment Director, Longwall Venture Partners


12:40 Lavima Fertility

 


12:50 Aligned Bio AB

 


13:00 Calla Lily Clinical Care

 


13:10

Sendance

 


13:20

CompreVie

 


13:30

Nanovery

 


13:40

SMi Systems

 


13:50 Implant Preservation Devices

 


14:00

Mabsilico

 


14:10 Concinnity Genetics

 


14:20 SurePulse Medical Ltd

 


14:30

Pharma Collaborations: Failures to Successes

Within the scope of this overarching theme, we have the opportunity to delve into a multitude of subjects, including: 

  • Examining the challenges in pharma-medtech/DTX startup partnerships. 
  • A comparative exploration of what startups and pharma enterprises bring to the table, and what they seek from each other. 
  • The investor's lens - A critical perspective on the dynamics of startup-pharma partnerships. 
  • Navigating the path to the ideal collaborative allianc

Moderated: Anne Horgan, Partner, Cambridge Innovation Capital
Charles Conn, Co-Founder & Partner, Monograph Capital
Richard Cassidy, SVP, Rx+ Business Accelerator, Astellas 
Daria Gherghelas, Investor, Speedinvest

Anne Horgan partner Cambridge Innovation Capitaljpg   Charles Conn, Co-founder and Partner, Monograph Capital  Richard Cassidy, VP Rx+Global, Astellas Pharma  Daria Gherghelas, Investor, Speedinvest


15:00 Pinpoint Molecular

 


15:10 Cancerappy

 


15:20

Keyron Logo

 


15:30

iHeF Logo

 


15:40

XRnostics Logo

 


15:50

Rhythm DIagnostic Systems


16:00

STENTiT Logo

 


16:10

Aliform Logo

 


16:20

EarlySight Logo

 


16:30

Tada Group Logo

 


17:00

Drinks Reception


18:00

Close of Investival Showcase


18:30

Lifestars Logo

Awards & Gala Dinner
- Separate ticket required
- Find out more

DOWNLOAD BROCHURE